These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 16173923)

  • 41. Glucocorticoid hormones and early brain development in schizophrenia.
    Koenig JI; Kirkpatrick B; Lee P
    Neuropsychopharmacology; 2002 Aug; 27(2):309-18. PubMed ID: 12093605
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hyperthermia in utero due to maternal influenza is an environmental risk factor for schizophrenia.
    Edwards MJ
    Congenit Anom (Kyoto); 2007 Sep; 47(3):84-9. PubMed ID: 17688466
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Factoring neurotrophins into a neurite-based pathophysiological model of schizophrenia.
    Bellon A; Krebs MO; Jay TM
    Prog Neurobiol; 2011 Jun; 94(1):77-90. PubMed ID: 21515336
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic insights into the neurodevelopmental origins of schizophrenia.
    Birnbaum R; Weinberger DR
    Nat Rev Neurosci; 2017 Dec; 18(12):727-740. PubMed ID: 29070826
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Schizophrenia in childhood and adolescence.
    Mala E
    Neuro Endocrinol Lett; 2008 Dec; 29(6):831-6. PubMed ID: 19112396
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recent advances in postmortem pathology and neurochemistry in schizophrenia.
    Dean B; Boer S; Gibbons A; Money T; Scarr E
    Curr Opin Psychiatry; 2009 Mar; 22(2):154-60. PubMed ID: 19553869
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia.
    Ozawa K; Hashimoto K; Kishimoto T; Shimizu E; Ishikura H; Iyo M
    Biol Psychiatry; 2006 Mar; 59(6):546-54. PubMed ID: 16256957
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An organelle proteomic method to study neurotransmission-related proteins, applied to a neurodevelopmental model of schizophrenia.
    Vercauteren FG; Flores G; Ma W; Chabot JG; Geenen L; Clerens S; Fazel A; Bergeron JJ; Srivastava LK; Arckens L; Quirion R
    Proteomics; 2007 Oct; 7(19):3569-79. PubMed ID: 17907268
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Can concepts of neurodevelopment and neuroplasticity explain post-traumatic psychoses?].
    Thomas G; Genest P; Walter M; Cozic JY
    Neurochirurgie; 2009 Feb; 55(1):36-9. PubMed ID: 19059615
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The etiopathogenesis of schizophrenias.
    Kornhuber J; Wiltfang J; Bleich S
    Pharmacopsychiatry; 2004 Nov; 37 Suppl 2():S103-12. PubMed ID: 15546061
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Schizophrenia and phenotypic plasticity: schizophrenia may represent a predictive, adaptive response to severe environmental adversity that allows both bioenergetic thrift and a defensive behavioral strategy.
    Reser JE
    Med Hypotheses; 2007; 69(2):383-94. PubMed ID: 17321061
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Neuropathology of scizophrenia--from a new perspective].
    Iritani S
    Brain Nerve; 2007 Jun; 59(6):605-16. PubMed ID: 17585592
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Review: Role of developmental inflammation and blood-brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases.
    Stolp HB; Dziegielewska KM
    Neuropathol Appl Neurobiol; 2009 Apr; 35(2):132-46. PubMed ID: 19077110
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is schizophrenia a neurodegenerative disorder?
    Rund BR
    Nord J Psychiatry; 2009; 63(3):196-201. PubMed ID: 19235629
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Behavioral and hippocampal changes after prenatal invasive interventions with possible relevance to schizophrenia.
    Sprick U; von Wilmsdorff M; Bouvier ML; Schulz D; Gaebel W
    Behav Brain Res; 2006 Sep; 172(2):179-86. PubMed ID: 16806517
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immune involvement in schizophrenia and autism: etiology, pathology and animal models.
    Patterson PH
    Behav Brain Res; 2009 Dec; 204(2):313-21. PubMed ID: 19136031
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prenatal and postnatal animal models of immune activation: relevance to a range of neurodevelopmental disorders.
    Harvey L; Boksa P
    Dev Neurobiol; 2012 Oct; 72(10):1335-48. PubMed ID: 22730147
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pathophysiology of early onset schizophrenia.
    Kyriakopoulos M; Frangou S
    Int Rev Psychiatry; 2007 Aug; 19(4):315-24. PubMed ID: 17671865
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gene-environment interaction during early development in the heterozygous reeler mouse: clues for modelling of major neurobehavioral syndromes.
    Laviola G; Ognibene E; Romano E; Adriani W; Keller F
    Neurosci Biobehav Rev; 2009 Apr; 33(4):560-72. PubMed ID: 18845182
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Models of schizophrenia in humans and animals based on inhibition of NMDA receptors.
    Bubeníková-Valesová V; Horácek J; Vrajová M; Höschl C
    Neurosci Biobehav Rev; 2008 Jul; 32(5):1014-23. PubMed ID: 18471877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.